Live Breaking News & Updates on Manag Care Spec

Stay updated with breaking news from Manag care spec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Economic Burden of Nonadherence to Standards of Diabetes Care

Using propensity score matching in a US nationally representative sample, authors found the effect of nonadherence to diabetes guidelines on health care expenditures of patients with diabetes. ....

United States , United Kingdom , University Of Houston , Mcadam Marx , Bekker Hansen , Sujits Sansgiry , Department Of Pharmaceutical Health Outcomes , Health Expenditure Outcomes , Federal Reserve Bank , National Drug Codes , School Of Pharmacy , National Drug Code , Qual Manag Health Care , Institute Inc , American Diabetes Association , Expenditure Panel , University Of Maryland Baltimore , Health Soc Behav , National Diabetes Statistics , Biomedical Sciences Building , Wolters Kluwer , Agency For Healthcare Research , International Classification Of Diseases , Health Outcomes Research , Eurj Health Econ , Department Of Practice ,

Challenges in Reimbursement for Pharmacy Services, DIR Fees, and the Evolving PBM Model

Amid various obstacles, health care providers and pharmacists can initiate measures to enhance compensation for pharmacy services in managed care. ....

United States , National Community Pharmacists Association , American Pharmacists Association , Public Health , Journal Of The American Pharmacists Association , Managed Care , Specialty Pharmacy , Accessed May , Manag Care Spec , Community Pharmacists , American Pharmacists ,

Better Together? Costs of First-line Chemoimmunotherapy for Advanced Non–Small Cell Lung Cancer

Compared with first-line immunotherapy or chemotherapy alone, combination chemoimmunotherapy for advanced/metastatic non–small cell lung cancer has significantly higher antineoplastic drug and associated medical costs. ....

United States , Alexandrina Balanean , Dacosta Byfield , Alex Jansen , Bristol Myers Squibb , Bruce Feinberg , Bernabe Caro , Danielle Gentile , Cardinal Health , Wolters Kluwer , National Cancer Institute Surveillance , End Results Program , Oncology Care Model , Enhanced Oncology Model , Ability Patient Complete , Current Procedural Terminology , Consumer Price Index , Charlson Comorbidity Index , Bristol Myers , Cancer Institute Surveillance , End Results , Accessed September , Accessed July , Accessed October , Manag Care Spec , Lung Cancer ,

Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use

Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy. ....

New York , United States , Kyle Cook , Shelleya Jazowski , Ann Pharmacother , Latinx White , Strategic Initiative Of University North Carolina , National Academies , National Academy For State Health , Medicare Payment Advisory Commission , Health Serv Res , School Of Medicine , Department Of Population Health Sciences , Institute For Clinical , J Public Health , University Of North Carolina At Chapel Hill , Information Management Services Ims Inc , Goodrx Health , Lineberger Comprehensive Cancer Center , Vanderbilt Ingram Cancer Center , Institute Of Medicine , Institute Inc , Department Of Medicine , Vanderbilt University School Of Medicine , Agency For Healthcare Research , Leukemia Lymphoma Society ,

Four Analyses of Data for REBYOTA fecal microbiota live jslm the First FDAApproved MicrobiomeBased Treatment for the Prevention of Recurrent C. difficile Infection Presented at DDW 2023

Ferring Pharmaceuticals today announced three oral presentations and one poster presentation at Digestive Disease Week DDW 2023 for REBYOTA fecal microbiota live jslm a firstinclass singledose microbiomebased treatment approved by the U.S. Food and Drug Administration FDA for the prevention of recurrent C. difficile C. diff infection in individuals 18 years of age and older following antibiotic treatment for recurrent C. diff infection. ....

United States , Jessica Allegretti , Paul Feuerstadt , Centers For Disease , American Society For Gastrointestinal Endoscopy , Society For Surgery Of The Alimentary Tract , American Gastroenterological Association , Ferring Pharmaceuticals , Yale University School Of Medicine , Drug Administration , Digestive Disease , Assured Active Treatment , Yale University School , American Association , Liver Diseases , American Society , Gastrointestinal Endoscopy , Alimentary Tract , Disease Control , Dis Clin North , Manag Care Spec , Clin Microbiol , Rev Dis , Media Contact , Ferring Pharmaceuticals Rebyota Fecal Microbiota Fdac Difficile Infection Ddw 2023 Colonoscopy Microbiome Composition Clonal Engraftment Digestive Disease Week Food And Drug Administration Rbx2660 Inflammatory Bowel Immunocompromised Patients Clostridioides Phase 3 Punch Cd3 Ols Trial Teaes Medication Jessica Allegretti Assured Active Treatment Bacteroidia Clostridia ,